DexCom, Inc.
83.88USD
-0.6500 (-0.77%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.67▼ | $0.67 | 7 | 9 |
| Next quarter | $0.73▼ | $0.74 | 5 | 12 |
| Current year | $2.66▲ | $2.58 | 23 | 0 |
| Next year | $3.12▲ | $3.06 | 18 | 4 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.61 | $0.7 | +0.09 (+15.1%) |
| 2026-03-31 | $0.47 | $0.56 | +0.09 (+19.0%) |
| 2025-12-31 | $0.65 | $0.68 | +0.03 (+4.5%) |
| 2025-09-30 | $0.57 | $0.61 | +0.04 (+7.5%) |
355 ratings from 47 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Argus Research | Maintained | Buy | $86 $96 | Aug 4, 2026 |
| Canaccord Genuity | Maintained | Buy | $82 $90 | Aug 3, 2026 |
| Citigroup | Maintained | Buy | $84 $88 | Jul 31, 2026 |
| RBC Capital | Maintained | Outperform | $85 $90 | Jul 31, 2026 |
| Mizuho | Maintained | Outperform | $90 $95 | Jul 31, 2026 |
| JP Morgan | Maintained | Neutral | $65 $82 | Jul 31, 2026 |
| Piper Sandler | Reiterated | Overweight | $88 $95 | Jul 31, 2026 |
| Wells Fargo | Maintained | Overweight | $85 $90 | Jul 31, 2026 |
| Stifel | Maintained | Buy | $90 $95 | Jul 31, 2026 |
| Benchmark | Maintained | Buy | $77 $82 | Jul 31, 2026 |
| Truist Securities | Maintained | Buy | $87 $93 | Jul 31, 2026 |
| BTIG | Maintained | Buy | $80 $90 | Jul 31, 2026 |
| Truist Securities | Maintained | Buy | $80 $87 | Jul 16, 2026 |
| Mizuho | Maintained | Outperform | $85 $90 | Jul 15, 2026 |
| Deutsche Bank | Initiated | Buy | $86 | Jun 23, 2026 |
| Piper Sandler | Maintained | Overweight | $75 $88 | Jun 15, 2026 |
| TD Cowen | Maintained | Buy | $75 $95 | Jun 10, 2026 |
| Mizuho | Maintained | Outperform | $75 $85 | Jun 9, 2026 |
| Stifel | Maintained | Buy | $85 $90 | Jun 5, 2026 |
| Citigroup | Maintained | Buy | $79 $84 | May 28, 2026 |
| Canaccord Genuity | Maintained | Buy | $100 $82 | May 18, 2026 |
| B of A Securities | Maintained | Buy | $100 $80 | May 18, 2026 |
| Barclays | Maintained | Underweight | $67 $64 | May 18, 2026 |
| Citigroup | Maintained | Buy | $84 $79 | May 4, 2026 |
| Canaccord Genuity | Maintained | Buy | $95 $100 | May 1, 2026 |
113 filings from 19 insiders · 21 buy / 16 sell over 6m
Officers and directors of DXCM, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| STERN SADIEOfficer | Sell | 2.6k | $88.37 | $227k | Aug 27, 2026 |
| SAYER KEVIN ROfficer and Director | Sell | 26.8k | $89.71 | $2.41M | Aug 20, 2026 |
| BROWN MICHAEL JONOfficer | Sell | 1.7k | $91.93 | $156k | Aug 14, 2026 |
| AUGUSTINOS NICHOLASDirector | Giftindirect | 1.1k | — | — | Aug 12, 2026 |
| HELLER BRIDGETTE PDirector | Sell | 1.0k | $88.29 | $89k | Aug 12, 2026 |
| FOLETTA MARK GDirector | Sellindirect | 4.0k | $80.00 | $331k | Aug 3, 2026 |
| SAYER KEVIN ROfficer and Director | Sell | 26.8k | $76.32 | $2.04M | Jul 20, 2026 |
| BROWN MICHAEL JONOfficer | Sell | 1.7k | $74.42 | $127k | Jul 15, 2026 |
| SAYER KEVIN ROfficer and Director | Sell | 26.8k | $72.00 | $1.93M | Jul 6, 2026 |
| BROWN MICHAEL JONOfficer | Sell | 1.7k | $75.55 | $128k | Jun 15, 2026 |
| FOLETTA MARK GDirector | Sellindirect | 4.0k | $74.10 | $297k | Jun 15, 2026 |
| COLEMAN JONOfficer | Sell | 9.8k | $73.00 | $723k | Jun 4, 2026 |
| FOLETTA MARK GDirector | Grant | 6.3k | — | — | May 28, 2026 |
| HELLER BRIDGETTE PDirector | Grant | 5.6k | — | — | May 28, 2026 |
| AUGUSTINOS NICHOLASDirector | Grant | 5.6k | — | — | May 28, 2026 |
| ALTMAN STEVEN RDirector | Grant | 5.6k | — | — | May 28, 2026 |
| GALA RENEE DDirector | Grant | 5.6k | — | — | May 28, 2026 |
| COLLINS RICHARD ALEXANDERDirector | Grant | 5.6k | — | — | May 28, 2026 |
| MALADY KYLEDirector | Grant | 5.6k | — | — | May 28, 2026 |
| DRISCOLL RIMMADirector | Grant | 5.6k | — | — | May 28, 2026 |
No analyst notes on DXCM yet.
Analyst Ratings
25 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 3 | 22 | 3 | 0 | 0 | Buy2.00 |
| 1 mo ago | 3 | 22 | 3 | 0 | 0 | Buy2.00 |
| 2 mo ago | 3 | 22 | 3 | 0 | 0 | Buy2.00 |